Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?

J Am Coll Cardiol. 2019 Aug 20;74(7):902-904. doi: 10.1016/j.jacc.2019.07.008.

Authors

John J V McMurray¹, Kieran F Docherty²

Affiliations

¹ Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
² Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: https://twitter.com/Kieranfdocherty.

PMID: 31416534
DOI: 10.1016/j.jacc.2019.07.008

No abstract available

Keywords: cyclic guanosine monophosphate; heart failure; natriuretic peptides; phosphodiesterase-9.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Heart Failure*
Hemodynamics
Humans
Natriuretic Peptides*
Phosphoric Diester Hydrolases

Substances

Natriuretic Peptides
Phosphoric Diester Hydrolases